| scholarly article | Q13442814 |
| P356 | DOI | 10.1034/J.1399-0039.2003.00070.X |
| P953 | full work available online at | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1399-0039.2003.00070.x |
| https://onlinelibrary.wiley.com/doi/pdf/10.1034/j.1399-0039.2003.00070.x | ||
| P698 | PubMed publication ID | 12753652 |
| P50 | author | Adelheid Cerwenka | Q96106107 |
| P2093 | author name string | L. L. Lanier | |
| P2860 | cites work | Ligands for natural killer cell receptors: redundancy or specificity | Q34341435 |
| The centromeric part of the human natural killer (NK) receptor complex: lectin-like receptor genes expressed in NK, dendritic and endothelial cells | Q34341499 | ||
| Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. | Q35874845 | ||
| NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules | Q36370410 | ||
| Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity | Q37509338 | ||
| MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal | Q40718577 | ||
| Cutting edge: the minor histocompatibility antigen H60 peptide interacts with both H-2Kb and NKG2D. | Q40743375 | ||
| High Levels of RAE-1 Isoforms on Mouse Tumor Cell Lines Assessed by Anti-“pan” RAE-1 Antibody Confer Tumor Susceptibility to NK Cells | Q40758810 | ||
| The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex | Q40898237 | ||
| One step ahead of the game: viral immunomodulatory molecules | Q41039669 | ||
| Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin | Q44209275 | ||
| MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. | Q45732476 | ||
| Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. | Q46027985 | ||
| Impairment of NK cell function by NKG2D modulation in NOD mice | Q46830266 | ||
| NK cell receptors | Q46858751 | ||
| MIC-A polymorphism in Japanese and a MIC-A-MIC-B null haplotype. | Q47955791 | ||
| Inhibitory MHC class I receptors on NK and T cells: a standard nomenclature | Q48787037 | ||
| Molecular Competition for NKG2D | Q55951804 | ||
| Severe herpesvirus infections in an adolescent without natural killer cells | Q55984308 | ||
| Cutting Edge: Down-Regulation of MICA on Human Tumors by Proteolytic Shedding | Q57257284 | ||
| Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation | Q59055770 | ||
| Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin | Q73740416 | ||
| Immunodominance of H60 is caused by an abnormally high precursor T cell pool directed against its unique minor histocompatibility antigen peptide | Q78518647 | ||
| Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB | Q22009950 | ||
| An activating immunoreceptor complex formed by NKG2D and DAP10 | Q22010441 | ||
| Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells | Q24290869 | ||
| Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family | Q24291540 | ||
| DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells | Q24295237 | ||
| Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity | Q24303742 | ||
| Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells | Q24315619 | ||
| Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium | Q24318429 | ||
| DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells | Q24675903 | ||
| Regulation of cutaneous malignancy by gammadelta T cells | Q28188439 | ||
| NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation | Q28214524 | ||
| Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D | Q28214530 | ||
| UL16-Binding Proteins, Novel MHC Class I-Related Proteins, Bind to NKG2D and Activate Multiple Signaling Pathways in Primary NK Cells | Q28214601 | ||
| A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3 | Q28217434 | ||
| Differences that matter: major cytotoxic T cell-stimulating minor histocompatibility antigens | Q28506733 | ||
| Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: one of the early inducible clones encodes a novel protein sharing several highly homologous regions with a Drosophila polyhomeotic protein | Q28591829 | ||
| Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice | Q28591835 | ||
| Asymmetric ligand recognition by the activating natural killer cell receptor NKG2D, a symmetric homodimer | Q28610392 | ||
| Regulation of immune responses through inhibitory receptors | Q33652541 | ||
| Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. | Q33908939 | ||
| Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo | Q33944680 | ||
| MIC genes: from genetics to biology | Q34082781 | ||
| A novel secreted tumor antigen with a glycosylphosphatidylinositol-anchored structure ubiquitously expressed in human cancers | Q34083434 | ||
| Natural killer cells, viruses and cancer | Q34119645 | ||
| The role of the NKG2D immunoreceptor in immune cell activation and natural killing | Q34142062 | ||
| Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. | Q34153562 | ||
| A family of MHC class I-like genes located in the vicinity of the mouse leukocyte receptor complex | Q34160522 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biochemistry | Q7094 |
| genetics | Q7162 | ||
| immunology | Q101929 | ||
| P304 | page(s) | 335-343 | |
| P577 | publication date | 2003-05-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Tissue Antigens | Q1573131 |
| P1476 | title | NKG2D ligands: unconventional MHC class I-like molecules exploited by viruses and cancer | |
| NKG2D ligands: unconventional MHC class I‐like molecules exploited by viruses and cancer | |||
| P478 | volume | 61 |
| Q33319278 | A role for NKG2D in NK cell-mediated resistance to poxvirus disease |
| Q33292224 | A soluble fragment of the tumor antigen BCL2-associated athanogene 6 (BAG-6) is essential and sufficient for inhibition of NKp30 receptor-dependent cytotoxicity of natural killer cells |
| Q39839714 | Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase |
| Q36652166 | Activation, coactivation, and costimulation of resting human natural killer cells |
| Q33305767 | Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunoreceptors as an immunological tool |
| Q35973425 | An innately interesting decade of research in immunology |
| Q26865509 | Beneficial autoimmunity at body surfaces - immune surveillance and rapid type 2 immunity regulate tissue homeostasis and cancer |
| Q35837364 | Changes in natural killer cell subsets in pediatric liver transplant recipients |
| Q36981178 | Common themes in the assembly and architecture of activating immune receptors |
| Q38076687 | Concise review: immunologic lessons from solid organ transplantation for stem cell-based therapies. |
| Q41084758 | Consuming Lentinula edodes (Shiitake) Mushrooms Daily Improves Human Immunity: A Randomized Dietary Intervention in Healthy Young Adults |
| Q34402566 | Costimulation of dendritic epidermal gammadelta T cells by a new NKG2D ligand expressed specifically in the skin |
| Q44558952 | Could interleukin-15 potentiate histone deacetylase inhibitor effects in haematological malignancy? |
| Q40749737 | Downregulation of the stress-induced ligand ULBP1 following SV40 infection confers viral evasion from NK cell cytotoxicity |
| Q50753300 | Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients |
| Q34313946 | Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts |
| Q35123311 | Gain of virulence caused by loss of a gene in murine cytomegalovirus |
| Q33516121 | Gene medicine for cancer treatment: commercially available medicine and accumulated clinical data in China |
| Q40350159 | Gene transfer of vasostatin, a calreticulin fragment, into neuroendocrine tumor cells results in enhanced malignant behavior |
| Q38017839 | Glycan Ligand Specificity of Killer Lectin Receptors |
| Q34759678 | Glycosylation contributes to variability in expression of murine cytomegalovirus m157 and enhances stability of interaction with the NK-cell receptor Ly49H. |
| Q84291590 | High Resolution MICA Genotyping by Sequence-Based Typing (SBT) |
| Q33522918 | Human IgG1 antibodies antagonizing activating receptor NKG2D on natural killer cells |
| Q35795227 | Human MHC class I chain related (MIC) genes: their biological function and relevance to disease and transplantation |
| Q39313746 | Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells |
| Q39747252 | Human herpesvirus 7 u21 downregulates classical and nonclassical class I major histocompatibility complex molecules from the cell surface |
| Q39600950 | IDO metabolite produced by EBV-transformed B cells inhibits surface expression of NKG2D in NK cells via the c-Jun N-terminal kinase (JNK) pathway |
| Q37060710 | Immune evasion of natural killer cells by viruses |
| Q61798312 | In vitro culture with gemcitabine augments death receptor and NKG2D ligand expression on tumour cells |
| Q56956215 | Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus |
| Q33914699 | Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1 |
| Q40551456 | MICA intron 1 sequences of conserved extended HLA haplotypes: implications for sequencing-based typing |
| Q36309488 | Matrine increases NKG2D ligand ULBP2 in K562 cells via inhibiting JAK/STAT3 pathway: a potential mechanism underlying the immunotherapy of matrine in leukemia |
| Q41639162 | Matrine regulates immune functions to inhibit the proliferation of leukemic cells. |
| Q37876089 | Mechanisms of Tumor and Viral Immune Escape from Natural Killer Cell-Mediated Surveillance |
| Q37079834 | Murine cytomegalovirus regulation of NKG2D ligands. |
| Q36402602 | NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. |
| Q36543814 | NK cell receptors as tools in cancer immunotherapy. |
| Q37891799 | NK cells and psoriasis |
| Q92702533 | NKG2D Polymorphism in Melanoma Patients from Southeastern Spain |
| Q36354709 | NKG2D in NK and T cell-mediated immunity |
| Q33920066 | NKG2D-independent suppression of T cell proliferation by H60 and MICA. |
| Q37375443 | Naive mouse macrophages become activated following recognition of L5178Y lymphoma cells via concurrent ligation of CD40, NKG2D, and CD18 molecules |
| Q35678024 | Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection. |
| Q35622883 | Natural killer cells and cancer |
| Q42796257 | New prospects on the NKG2D/NKG2DL system for oncology |
| Q39894593 | Obstructing shedding of the immunostimulatory MHC class I chain-related gene B prevents tumor formation |
| Q35982170 | Perspectives on cancer immuno-epidemiology |
| Q36652177 | Physiological roles of murine DAP10 adapter protein in tumor immunity and autoimmunity |
| Q39676621 | Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer |
| Q40108262 | Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells |
| Q38951511 | Regulatory properties of statins and rho gtpases prenylation inhibitiors to stimulate melanoma immunogenicity and promote anti-melanoma immune response. |
| Q36388793 | Role of apolipoproteins in gammadelta and NKT cell-mediated innate immunity. |
| Q33834018 | Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein |
| Q35561646 | Stress management: MHC class I and class I-like molecules as reporters of cellular stress |
| Q37445751 | Structure and function of murine cytomegalovirus MHC-I-like molecules: how the virus turned the host defense to its advantage. |
| Q52714311 | Super-charged NK cells inhibit growth and progression of stem-like/poorly differentiated oral tumors in vivo in humanized BLT mice; effect on tumor differentiation and response to chemotherapeutic drugs. |
| Q36757142 | T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice |
| Q57614238 | Taking the lead – how keratinocytes orchestrate skin T cell immunity |
| Q33836365 | The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure. |
| Q38084615 | The evolutionary arms race between NK cells and viruses: who gets the short end of the stick? |
| Q40302036 | The human cytomegalovirus glycoprotein UL16 traffics through the plasma membrane and the nuclear envelope |
Search more.